PreveCeutical develops proprietary method for extracting cannabinoids for Sol-gel

0 views
0%

PreveCeutical Medical INC. (CSE:PREV) CEO and President Stephen Van Deventer joined Steve Darling in the Vancouver studio of Proactive Investors to talk …

From:
Date: December 26, 2020

Leave a Reply

Your email address will not be published. Required fields are marked *